Cargando…

Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

BACKGROUND: The effect of interferon(IFN) in the management of hepatocellular carcinoma (HCC) remains controversial, and no clear recommendations have been proposed. OBJECTIVES: To evaluate the effect and safety of IFN for HCC. METHODS: PubMed, OvidSP, and Cochrane Library were searched from their e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Liping, Zeng, Xiantao, Yang, Zongguo, Meng, Zhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775819/ https://www.ncbi.nlm.nih.gov/pubmed/24069133 http://dx.doi.org/10.1371/journal.pone.0061361

Ejemplares similares

Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
por: Zhuang, Liping, et al.
Publicado: (2018)

Oncogenic Roles of RAD51AP1 in Tumor Tissues Related to Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma
por: Zhuang, Liping, et al.
Publicado: (2020)

MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients
por: Zhuang, Liping, et al.
Publicado: (2021)

Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis
por: Yang, Zongguo, et al.
Publicado: (2016)

HMGCS2 in metabolic pathways was associated with overall survival in hepatocellular carcinoma: A LASSO-derived study
por: Ding, Rongrong, et al.
Publicado: (2021)

Hepatocellular Carcinoma More Than 3 cm in Diameter: A Systematic Review of Transcatheter Arterial Chemoembolization Plus Percutaneous Ethanol Injection versus Transcatheter Arterial Chemoembolization Alone
por: Wang, Shiying, et al.
Publicado: (2013)

Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials
por: Yang, Zongguo, et al.
Publicado: (2013)

A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma
por: Jiang, Shaojie, et al.
Publicado: (2013)

Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis
por: Liu, Xuefeng, et al.
Publicado: (2019)

Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis
por: Ding, Ziniu, et al.
Publicado: (2021)

Effects and Tolerance of Silymarin (Milk Thistle) in Chronic Hepatitis C Virus Infection Patients: A Meta-Analysis of Randomized Controlled Trials
por: Yang, Zongguo, et al.
Publicado: (2014)

Accuracy of Non-Contrast MRI for the Detection of Hepatocellular Carcinoma: A systematic review and meta-analysis
por: Lu, Liping, et al.
Publicado: (2022)

Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis
por: Tao, Yuquan, et al.
Publicado: (2018)

Serum miR-128-2 Serves as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Zhuang, Liping, et al.
Publicado: (2015)

The Oncogenic Role of CENPA in Hepatocellular Carcinoma Development: Evidence from Bioinformatic Analysis
por: Zhang, Yuan, et al.
Publicado: (2020)

Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
por: Hsu, Ching-Sheng, et al.
Publicado: (2015)

Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis
por: Kulkarni, Anand V., et al.
Publicado: (2023)

A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
por: Huang, Shenglan, et al.
Publicado: (2021)

Add-On Therapy with Traditional Chinese Medicine Improves Outcomes and Reduces Adverse Events in Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials
por: Yang, Zongguo, et al.
Publicado: (2017)

Interferon-γ +874A/T Polymorphism and Hepatocellular Carcinoma Risk: A Meta-Analysis
por: Zhou, Huan, et al.
Publicado: (2015)

Upregulation of Heat Shock Proteins (HSPA12A, HSP90B1, HSPA4, HSPA5 and HSPA6) in Tumour Tissues Is Associated with Poor Outcomes from HBV-Related Early-Stage Hepatocellular Carcinoma
por: Yang, Zongguo, et al.
Publicado: (2015)

Efficacy and safety of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma: A systematic review and meta-analysis
por: Dou, Zhimin, et al.
Publicado: (2022)

The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis
por: Li, Ping, et al.
Publicado: (2023)

Systemic inflammation response index (SIRI) predicts prognosis in hepatocellular carcinoma patients
por: Xu, Litao, et al.
Publicado: (2017)

Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study
por: Guo, Wenbo, et al.
Publicado: (2020)

Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis
por: Yan, Lun-Jie, et al.
Publicado: (2022)

Comparative effectiveness of different hepatocellular carcinoma screening intervals or modalities: a systematic review and meta-analysis
por: Yang, Jichun, et al.
Publicado: (2023)

Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
por: Li, Xinyang, et al.
Publicado: (2021)

Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis
por: Xu, Jingjing, et al.
Publicado: (2021)

Safety and Feasibility of Microwave Ablation for Hepatocellular Carcinomas in the Elderly: A Systematic Review
por: Liang, Weiren, et al.
Publicado: (2022)

Regulatory T cell and activated natural killer cell infiltration in hepatocellular carcinoma: immune cell profiling using the CIBERSORT
por: Wang, Lixin, et al.
Publicado: (2020)

Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis
por: Yang, Xiaoyu, et al.
Publicado: (2022)

Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review
por: Yang, Shu, et al.
Publicado: (2016)

Comparison of the efficacy and safety of selective internal radiotherapy and sorafenib alone or combined for hepatocellular carcinoma: a systematic review and Bayesian network meta-analysis
por: Zeng, Hao, et al.
Publicado: (2023)

Vasopressors in septic shock: a systematic review and network meta-analysis
por: Zhou, Feihu, et al.
Publicado: (2015)

Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
por: Zhou, Yao-Yao, et al.
Publicado: (2016)

Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma
por: Zhou, Xueliang, et al.
Publicado: (2022)

Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Liu, Xinyang, et al.
Publicado: (2018)

Safety of Intraoperative Blood Salvage During Liver Transplantation in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
por: Aijtink, Virginia J., et al.
Publicado: (2022)

The hepatectomy efficacy of huge hepatocellular carcinoma and its risk factors: A meta analysis
por: Wang, Lei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0mhbtlk9tff2ta689mm46i07s0